Zeotech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Zeotech şirketinin toplam hissedar öz sermayesi A$11.5M ve toplam borcu A$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$12.8M ve A$1.3M dir.

Anahtar bilgiler

Borç/özkaynak oranı

AU$0

Borç

Faiz karşılama oranı	n/a
Nakit	AU$2.27m
Eşitlik	AU$11.54m
Toplam yükümlülükler	AU$1.30m
Toplam varlıklar	AU$12.84m

Son finansal sağlık güncellemeleri

Recent updates

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Aug 29

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

May 07

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Jan 20

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

Nov 21

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Mar 22

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Oct 27

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

Apr 19

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Feb 18

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Jan 25

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ZEO 'nin kısa vadeli varlıkları ( A$2.3M ) kısa vadeli yükümlülüklerini ( A$1.1M ) aşıyor.

Uzun Vadeli Yükümlülükler: ZEO şirketinin kısa vadeli varlıkları ( A$2.3M ) uzun vadeli yükümlülüklerini ( A$248.2K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ZEO borçsuzdur.

Borcun Azaltılması: ZEO un 5 yıl önce borcu yoktu.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: ZEO şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: ZEO un, serbest nakit akışı her yıl % 19 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Zeotech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Zeotech Limited to Be Deleted from Other OTC

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Recent updates

Zeotech Limited, Annual General Meeting, Nov 22, 2024

Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2023)

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Zeotech Limited Appoints Scott Burkhart as Chief Operating Officer

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

MD & Director exercised options and sold AU$232k worth of stock

First half 2024 earnings released: AU$0.002 loss per share (vs AU$0 in 1H 2023)

New major risk - Financial position

New major risk - Share price stability

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Insider recently sold AU$82k worth of stock

New minor risk - Share price stability

Zeotech Limited Announces CEO Changes, Anticipates to Occur from 1 November 2023

Zeotech Limited, Annual General Meeting, Nov 23, 2023

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2022)

New minor risk - Financial data availability

MD, COO & Director recently sold AU$135k worth of stock

First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022)

Zeotech Limited Appoints Alister Morrison as Chief Executive Officer, Effective 13 March 2023

MD, COO & Director exercised options to buy AU$490k worth of stock.

Zeotech Limited Announces Successful Completion of Pilot Program Accelerates Technology Development

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

No independent directors

Zeotech Limited, Annual General Meeting, Nov 28, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2021)

Zeotech Limited, Annual General Meeting, Aug 31, 2022

Zeotech Limited Achieves Successful Continuous Closed- Loop Circuit, Utilising Lithium Process By-Product Feedstock (Leached Spodumene) to Produce Pure Linde Type A Manufactured Zeolite

No independent directors

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Zeotech Limited to Be Deleted from Other OTC

Zeotech Limited Announces Pilot Program Update

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)

Zeotech Limited announced that it expects to receive AUD 3.7005 million in funding

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Zeotech Limited Pilot Plant Program Commences

Zeotech Limited Executes Research Agreement with UQ to Evaluate Carbon Capture Using Synthetic Zeolites

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Zeotech Limited Announces resignation of John Goody as Non-Executive Director

Metalsearch Limited Announces Participating in Agronomic Trials to Evaluate the Performance of Synthetic Zeolites Across A Range of Agricultural Applications

Full year earnings released

Metalsearch Limited announced that it has received AUD 1.6575 million in funding

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin